DONNA DEMOTT: Open Payments
NPI 1912604315 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 21 payments from 11 companies in 2025. Trend: 2023 $184 · 2024 $389 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $148 |
| PFIZER INC. | 4 | $77 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Lilly USA, LLC | 2 | $34 |
| Novo Nordisk Inc | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Orexo US, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $19 |
| Verona Pharma, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
Products named: AIRSUPRA, NURTEC ODT, TRELEGY ELLIPTA, REXULTI, Zubsolv, Cologuard Collection Kit, ZEPBOUND, Ohtuvayre.
Industry payments across MI — which companies pay providers there.
